What with all the hooraw in the media about climate change and global warming, it’s interesting to see that the FDA has approved a novel treatment — for severe frostbite.
That’s enough to make an Alaskan perk up and pay attention.
The Food and Drug Administration (FDA) has approved the first-ever treatment option for frostbite in adults.
The agency approved the Aurlumyn injection, which can help reduce the risk of finger or toe amputation, on Wednesday.
“Having this new option provides physicians with a tool that will help prevent the life-changing amputation of one’s frostbitten fingers or toes,” said Dr. Norman Stockbridge, the director of the Division of Cardiology and Nephrology in the FDA’s Center for Drug Evaluation and Research.
The active ingredient in Aurlumyn is iloprost, a vasodilator that prevents blood from clotting, showcasing efficacy in treating frostbite…
